CONMED Corp

CNMD · XNYS

CIK 816956fmd_1DHS73SQS74KER5PFRFYG1ED59Manufacturing · Electromedical & Electrotherapeutic ApparatusTemplate: Standard

Coverage: Jan 01, 2009 to Sep 30, 2026, 67 periods

Income Statement · Annual · Millions · USD
Line item	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Total revenues	764	796	860	955	862	1,011	1,045	1,245	1,307	1,375
Cost of revenue	355	365	391	430	402	443	474	568	574	624
Gross profit	408	431	469	525	460	568	571	676	733	750
Research and development	32	32	42	45	40	44	47	53	54	56
Selling, general and administrative	338	352	356	400	374	415	454	503	478	592
Gain on sale of real estate	2	0	0	–	–	–	–	–	–	–
Total operating expenses	371	384	398	446	414	458	501	556	533	648
Operating income	38	47	71	79	46	110	70	121	200	103
Interest expense	15	18	21	43	44	35	29	40	37	31
Income before taxes	19	29	51	31	2	73	(71)	81	163	71
Income tax expense	5	(27)	10	3	(8)	11	10	16	31	24
Net income from continuing operations	15	55	41	29	10	63	(81)	64	132	47
Net income	15	55	41	29	10	63	(81)	64	132	47
Net income to common shareholders	–	–	–	–	10	63	(81)	–	–	–